Viatris Inc beat Wall Street
estimates for second-quarter revenue on Monday, on the strength
of its branded drug portfolio, sending its shares up 2% in
premarket trading. The drugmaker.
Viatris Inc reaffirmed its full-year revenue forecast on Monday and said it was on track to achieve about $500 million in annual sales from its newly launched products, sending its shares up. | May 8, 2023
The U.S. Supreme Court on Monday declined to hear a bid by Sanofi SA to revive its antitrust lawsuit accusing rival pharmaceutical company Viatris Inc of illegally monopolizing the market with its
US Supreme Court Spurns Sanofi Appeal to Revive EpiPen Suit Against Viatris usnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from usnews.com Daily Mail and Mail on Sunday newspapers.
(Reuters) - Drugmaker Viatris Inc is considering a potential sale of its consumer health assets in Europe in a deal that could be valued at over 3 bil.